When mouse or patient T-ALL cells were co-cultured with tumor-associated or PBMC-derived myeloid cells, respectively, they exhibited fairly uniform sensitivity to FAK/PYK2 dual inhibitors, whereas the efficacy of inhibiting integrin-mediated cell adhesion varied between distinct primary T-ALLs. This evidence concerns the gene PTK2B and neoplasm.